REVB
Revelation Biosciences, Inc.
Revelation Biosciences, Inc. (REVB) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 57.4, with 1/3 trend checks passing.
REVB with MA50 and MA200
Key levels & signals
Revelation Biosciences, Inc. (REVB) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $1.09, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 5.7% and below the 200-day moving average by 55.7%.
REVB currently has an RSI reading of 57.4, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.
This page is designed to help you quickly understand what the REVB chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.
Learn the indicators behind this page
More stock opportunities
Common questions about REVB
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.